Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (34 ops.)
Latest filing published 04 Sept 2026 for Krystal Biotech, Inc., €159k. Read the official filing
Filing timeline
BuySaleKrish S. Krishnan
Insider track record
Disclosed buys
0
Disclosed sells
34
Signal history
Krish S. Krishnan: trading record in brief
This profile gathers the share dealings of Krish S. Krishnan across 2 companies, led by Krystal Biotech, Inc. and Precigen, Inc. We count 42 filings; the first trade dates from 28 January 2016 and the latest from 4 September 2026.
Sales make up the whole of the open-market record (34 sales, €25.5M). The rest of the record consists of 4 share grants and 4 option exercises. So far in 2026, the count stands at no purchases and 14 sales.
The record was last updated on 4 September 2026 with an open-market sale (€159k) in Krystal Biotech, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Krish S. Krishnan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations41 total
520 shares@ US$354.540.0018% mcap0.6% of flowCommon StockSEC:0001298709-26-000011:0
3,981 shares@ US$357.57380.014% mcap4.5% of flowCommon StockSEC:0001298709-26-000011:3
3,357 shares@ US$359.38610.012% mcap3.8% of flowCommon StockSEC:0001298709-26-000011:5
1,358 shares@ US$364.47940.0048% mcap1.6% of flowCommon StockSEC:0001298709-26-000011:10
2,029 shares@ US$355.57190.0070% mcap2.3% of flowCommon StockSEC:0001298709-26-000011:1
3,297 shares@ US$356.36870.011% mcap3.7% of flowCommon StockSEC:0001298709-26-000011:2
3,143 shares@ US$358.41820.011% mcap3.5% of flowCommon StockSEC:0001298709-26-000011:4
2,266 shares@ US$360.4630.0079% mcap2.6% of flowCommon StockSEC:0001298709-26-000011:6
1,214 shares@ US$361.60910.0042% mcap1.4% of flowCommon StockSEC:0001298709-26-000011:7
2,010 shares@ US$362.65040.0071% mcap2.3% of flowCommon StockSEC:0001298709-26-000011:8
573 shares@ US$363.34240.0020% mcap0.7% of flowCommon StockSEC:0001298709-26-000011:9
847 shares@ US$365.41630.0030% mcap1.0% of flowCommon StockSEC:0001298709-26-000011:11
405 shares@ US$366.55670.0014% mcap0.5% of flowCommon StockSEC:0001298709-26-000011:12
483 shares@ US$257.31310.0015% mcap0.4% of flowCommon StockSEC:0001298709-26-000004:0
8,750 shares0Common StockSEC:0001298709-26-000002:0
956 shares@ US$214.27970.6% of flowCommon StockSEC:0001298709-25-000013:0
13,400 shares@ US$150.29966.3% of flowCommon StockSEC:0001298709-25-000009:0
200 shares@ US$150.070.1% of flowCommon StockSEC:0001298709-25-000007:0
1,100 shares@ US$175.82560.6% of flowCommon StockSEC:0001298709-25-000004:0
4,721 shares@ US$176.392.9% of flowCommon StockSEC:0001298709-25-000002:0
6,302 shares@ US$163.0693.6% of flowCommon StockSEC:0001298709-24-000017:0
3,957 shares@ US$195.16272.5% of flowCommon StockSEC:0001298709-24-000014:0
1,100 shares@ US$171.4880.6% of flowCommon StockSEC:0001298709-24-000011:0
2,146 shares@ US$167.99221.2% of flowCommon StockSEC:0001298709-24-000009:0
12,500 shares0Common StockSEC:0001298709-24-000006:0
25 of 41 declarations
